Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Matthews International Reports Results for Fourth Quarter and Fiscal Year Ended September 30, 2024
-
Prairie Operating Co. Welcomes Energy Industry Veteran Richard N. Frommer to Its Board of Directors
-
/C O R R E C T I O N -- Northeast Science and Technology (NEST)/
-
SL Green Realty Corp. Announces Proposed Offering of Common Stock
-
Newmark's Executive Chairman Howard W. Lutnick Nominated for U.S. Secretary of Commerce
-
Wedbush Announces Support for 24-Hour Trading of U.S. Equities for Wedbush Correspondents
-
Pre-Registration Opens for Chiplet Summit
-
Portland Small Business Accountant, Downing & Co., Unveils Game-Changing Tax-Savings Strategy to Help Portland Clients Save Up to $1 Million in 2024
-
CSE Bulletin: Consolidation - Cypher Metaverse Inc. (CODE)
-
Sacramento Nonprofit Bookkeeping Firm, Daily Balance, Delivers Top Accounting Services for Nonprofits in the Community
-
H&M REOPENS ICONIC TIMES SQUARE FLAGSHIP IN NEW YORK CITY AS NEW BRAND SHOWCASE
-
/C O R R E C T I O N -- VISO TRUST/
-
Natural Grocers by Vitamin Cottage, Inc. Declares Quarterly Dividend
-
Duck Donuts® Expands Availability of Gift Cards to Major Retailers Nationwide, Just in Time for the Holidays
-
NXP Semiconductors Announces Quarterly Dividend
-
Natural Grocers by Vitamin Cottage Announces Fiscal 2024 Fourth Quarter and Full Year Results
-
Alexandria Real Estate Equities, Inc. Announces Long-Term 258,581 RSF Lease With Longstanding Tenant Vaxcyte, Inc. at the Alexandria Center for Life Science - San Carlos Mega Campus
-
Mirion to Present at Goldman Sachs’ Industrials and Materials Conference
-
Custom Truck One Source to Participate in the BofA Securities 2024 Leveraged Finance Conference
-
Alta Global Group Request for Withdrawal of Registration Statement on Form F-1
-
DisposeRx Celebrates Pharmacy as a Key Player in Decline of Overdose Deaths
-
Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States
-
BNY Mellon High Yield Strategies Fund Declares Dividend
-
Modular Medical Announces Proposed Public Offering
-
Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
-
NetApp Joins the Vultr Cloud Alliance to Provide Scalable Data Management for Enterprise AI Workloads
-
Smith & Wesson Brands, Inc. Second Quarter Fiscal 2025 Financial Release and Conference Call Alert
-
TeraWulf Announces Promotion of Sean Farrell to Chief Operating Officer
-
SL Green and Mori Building Co., Ltd. Complete Investment in One Vanderbilt Avenue
-
LEEF Brands, Inc. Successfully Completes 10:1 Share Consolidation
-
DT Midstream Announces Pricing of Offering of Senior Secured Notes
-
BGC's Howard W. Lutnick Nominated for U.S. Secretary of Commerce
-
Elastic Reports Second Quarter Fiscal 2025 Financial Results
-
Nanalysis Announces Third Quarter 2024 Results
-
eGain Announces Extension to Stock Repurchase Program
-
Methode Electronics to Announce Second Quarter Fiscal 2025 Results on Thursday, December 5, 2024
-
Logility Reports Second Quarter Fiscal Year 2025 Financial Results
-
Aflac Incorporated to Webcast 2024 Financial Analysts Briefing
-
Helen of Troy Limited Announces Agreement to Acquire Olive & June, LLC
-
American Outdoor Brands Second Quarter Fiscal 2025 Financial Release and Conference Call Alert
-
Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative
-
Stonegate Updates Coverage on Burcon Nutrascience Corporation (TSX: BU) FY25 Q2
-
S&P Global Market Intelligence's New Outlook Report Shows the Convergence of Public and Private Credit Markets and Expects the Trend to Continue into 2025
-
Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist
-
Lam Research Corporation Announces Participation at Upcoming Conferences
-
Replimune Receives Breakthrough Therapy Designation for RP1 and Submits RP1 Biologics License Application to the FDA under the Accelerated Approval Pathway
-
Spine BioPharma, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference
-
PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development
-
Farmers & Merchants Bank of Long Beach Declares Fourth-quarter Cash Dividend Payment of $28 Per Share; Also Declares Special Christmas Dividend of $15 Per Share
-
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

